Studies have shown that hydroxychloroquine has a role in reducing the risk of cardiovascular disease events in patients with traditional risk factors [68], while chloroquine diphosphate promotes caspase-3 and caspase-9 activity and increases AMI cardiomyocyte apoptosis [69]. The gene discussed is CASP9; the disease is cardiovascular disorder.